Address the four horsemen before they appear
Cardiovascular disease, cancer, neurodegeneration, and metabolic dysfunction have decades-long developmental trajectories — intervene early.
Key takeaways
- What it is: Cardiovascular disease, cancer, neurodegeneration, and metabolic dysfunction have decades-long developmental trajectories — intervene early.
- Why it works: Each of the four major chronic diseases has an extended pre-clinical phase: atherosclerosis begins in adolescence; metabolic syndrome develops over decades before diabetes; amyloid plaques accumulate 20 years before Alzheimer’s symptoms. Standard medicine intervenes when the disease is detectable; a healthspan-first approach intervenes at the causative risk factors (LDL particle number, insulin resistance, VO2 max, sleep architecture) when modification is most effective.
- Evidence: Backed by observational / correlational evidence.
- Avoid: Waiting for a symptom, a diagnosis, or a doctor’s concern before making lifestyle changes. By the time a condition is symptomatic, the pre-clinical window for the highest-leverage interventions has usually passed.
Why it works
Each of the four major chronic diseases has an extended pre-clinical phase: atherosclerosis begins in adolescence; metabolic syndrome develops over decades before diabetes; amyloid plaques accumulate 20 years before Alzheimer’s symptoms. Standard medicine intervenes when the disease is detectable; a healthspan-first approach intervenes at the causative risk factors (LDL particle number, insulin resistance, VO2 max, sleep architecture) when modification is most effective.
How to do it
- 1Get a comprehensive metabolic panel, lipid panel, and fasting glucose annually rather than waiting for symptoms.
- 2Request apolipoprotein B (ApoB) in addition to LDL cholesterol — ApoB is a more accurate cardiovascular risk predictor and is increasingly accessible.
- 3Track VO2 max, grip strength, and HbA1c — the physiological markers most predictive of the four horsemen — and set targets for each.
- 4If any marker is in the high-risk range, treat it as actionable now rather than waiting for it to worsen.
What the evidence says
ObservationalThe long pre-clinical phases of atherosclerosis, metabolic syndrome, and Alzheimer’s are well-documented. ApoB is validated as a superior cardiovascular risk biomarker versus LDL in multiple prospective studies. Early intervention evidence is primarily from cardiovascular trials.
Honest caveat: Early intervention for most of the four horsemen is supported by observational data and mechanistic understanding; long-term RCTs of prevention beginning in the 30s and 40s are difficult to run.
- — Sniderman et al. (2019), "ApoB versus non-HDL as a target for lipid-lowering," Journal of the American College of Cardiology
Common mistake
Waiting for a symptom, a diagnosis, or a doctor’s concern before making lifestyle changes. By the time a condition is symptomatic, the pre-clinical window for the highest-leverage interventions has usually passed.
IX Coach tracks your longitudinal biomarker data and flags early trends — not absolute thresholds — so you can see directional risk before a number crosses a diagnostic cutoff.
Practice this with IX Coach →